Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013 (2013), Article ID 343275, 5 pages
http://dx.doi.org/10.1155/2013/343275
Review Article

Biobanking in a Constantly Developing Medical World

1University of Medicine and Pharmacy of Craiova, Romania
2Bagdasar-Arseni Hospital, Bucharest, Romania
3Medico Science SRL, Craiova, Romania

Received 13 May 2013; Accepted 10 July 2013

Academic Editors: D. Matthopoulos and M. Mottolese

Copyright © 2013 Stefan-Alexandru Artene et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Organisation for Economic Co-operation and Development (OECD), Biological Resource Centres: Underpinning the Future of Life Sciences and Biotechnology, OECD, Paris, France, 2001.
  2. Council of Europe and Committee of Ministers, Recommendation Rec 4 of the Committee of Ministers to Member States on Research on Biological Materials of Human Origin, European Commission, Strasbourg, France, 2006.
  3. E. M. Melsin and K. Goodman, Biobanks and Electronic Health Records: Ethical and Policy Challenges in the Genomic Age, Indiana University Center for Applied Cybersecurity Research, Bloomington, Ind, USA, 2009.
  4. M. Yuille, K. Dixon, A. Platt et al., “The UK DNA banking network: a “fair access” biobank,” Cell and Tissue Banking, vol. 11, no. 3, pp. 241–250, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. http://www.coe.int/t/dg3/healthbioethic/Activities/10_Biobanks/biobanks_for_Europe.pdf.
  6. B. C. Goh, S. Thirumala, G. Kilroy, R. V. Devireddy, and J. M. Gimble, “Cryopreservation characteristics of adipose-derived stem cells: maintenance of differentiation potential and viability,” Journal of tissue engineering and regenerative medicine, vol. 1, no. 4, pp. 322–324, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Gourraud, L. Gilson, M. Girard, and M. Peschanski, “The role of human leukocyte antigen matching in the development of multiethnic “haplobank” of induced pluripotent stem cell lines,” Stem Cells, vol. 30, no. 2, pp. 180–186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Inoue, “Neurodegenerative disease-specific induced pluripotent stem cell research,” Experimental Cell Research, vol. 316, no. 16, pp. 2560–2564, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Terrenoire, K. Wang, K. W. C. Tung et al., “Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics,” The Journal of General Physiology, vol. 141, no. 1, p. 61, 2012. View at Google Scholar
  10. Y. S. Chun, P. Chaudhari, and Y. Jang, “Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease,” International Journal of Biological Sciences, vol. 6, no. 7, pp. 796–805, 2010. View at Google Scholar · View at Scopus
  11. C. Kelly, C. C. S. Flatt, and N. H. McClenaghann, “Stem cell-based approaches for the treatment of diabetes,” Stem Cells International, vol. 2011, Article ID 424986, 8 pages, 2011. View at Publisher · View at Google Scholar
  12. National Cancer Institute, “Best practices for biospecimen resources,” 2007, http://biospecimens.cancer.gov/global/pdfs/NCI_Best_Practices_060507.
  13. C. A. McCarty and R. A. Wilke, “Biobanking and pharmacogenomics,” Pharmacogenomics, vol. 11, no. 5, pp. 637–641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Spruessel, G. Steimann, M. Jung et al., “Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision,” BioTechniques, vol. 36, no. 6, pp. 1030–1037, 2004. View at Google Scholar · View at Scopus
  15. C. Womack and N. M. Gray, “Banking human tissue for research: vision to reality,” Cell and Tissue Banking, vol. 10, no. 3, pp. 267–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. R. Mager, M. H. A. Oomen, M. M. Morente et al., “Standard operating procedure for the collection of fresh frozen tissue samples,” European Journal of Cancer, vol. 43, no. 5, pp. 828–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. NCI, Best Practices for Specimen Resources, NCI, Bethesda, Md, USA, 2007, http://biospecimens.cancer.gov/global/pdfs/NCI_Best_Practices_060507.pdf.
  18. International Society for Biological and Environmental Repositories (ISBER), “Best practices for repositories: collection, storage, retrieval and distribution of biological materials for research,” Cell Preservation Technology, vol. 6, pp. 3–58, 2008. View at Google Scholar
  19. P. H. J. Riegman, W. N. M. Dinjens, M. H. A. Oomen et al., “TuBaFrost 1: uniting local frozen tumor banks into a European network, an overview,” European Journal of Cancer, vol. 42, no. 16, pp. 2678–2683, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. The Wellcome Trust, Sharing Research Data to Improve Public Health: Full Joint Statement by Funders of Health Research, Wellcome Trust, London, UK, 2011.
  21. M. G. Hansson, J. Dillner, C. R. Bartram, J. A. Carlson, and G. Helgesson, “Should donors be allowed to give broad consent to future biobank research?” The Lancet Oncology, vol. 7, no. 3, pp. 266–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. AORN, “Recommended practices for surgical tissue banking,” AORN Journal, vol. 83, no. 2, pp. 435–442, 2006. View at Google Scholar
  23. R. Mager, C. Ratcliff, and K. Knox, The NCRI Cancer Tissue Resource: Developing an Operational Framework, National Translational Cancer Research Network, Oxford, UK, 2004, http://www.ntrac.org.uk/Initiatives/NCTR/NCTR_SqOP_Report.pdf.
  24. W. E. Grizzle, R. Aamodt, K. Clausen, V. LiVolsi, T. G. Pretlow, and S. Qualman, “Providing human tissues for research: how to establish a program,” Archives of Pathology and Laboratory Medicine, vol. 122, no. 12, pp. 1065–1076, 1998. View at Google Scholar · View at Scopus
  25. S. Aldridge, “Biobanking emerging as a key growth area,” Genetic Engineering News, vol. 25, no. 3, pp. 1–2, 2005. View at Google Scholar · View at Scopus
  26. W. E. Grizzle, K. C. Sexton, and W. C. Bell, “Frontiers in clinical research: quality assurance in tissue resources supporting biomedical research,” Cell Preservation Technology, vol. 6, no. 2, pp. 113–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Tupasela, “Locating tissue collections in tissue economies—deriving value from biomedical research,” New Genetics and Society, vol. 25, no. 1, pp. 33–49, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. Office of Management and Budget (OMB), Supplement to the Circular A-11, Part 7, “Planning, Budgeting, Acquisition, and Management of Capital Assets Guide”, vol. 18, Section I. 5. 3. 2, 2006.
  29. S. Eriksson and G. Helgesson, “Potential harms, anonymization, and the right to withdraw consent to biobank research,” European Journal of Human Genetics, vol. 13, no. 9, pp. 1071–1076, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Hoeyer, B. Olofsson, T. Mjörndal, and N. Lynöe, “The ethics of research using biobanks: reason to question the importance attributed to informed consent,” Archives of Internal Medicine, vol. 165, no. 1, pp. 97–100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. K. J. Maschke, “Alternative consent approaches for biobank research,” The Lancet Oncology, vol. 7, no. 3, pp. 193–194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. F. J. Stjernschantz, M. G. Hansson, and S. Eriksson, “Biobank research: who benefits from individual consent?” British Medical Journal, vol. 343, p. d5647, 2011. View at Google Scholar · View at Scopus
  33. A. M. Clark and I. N. Findlay, “Attaining adequate consent for the use of electronic patient records: an opt-out strategy to reconcile individuals' rights and public benefit,” Public Health, vol. 119, no. 11, pp. 1003–1010, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Cambon-Thomsen, E. Rial-Sebbag, and B. M. Knoppers, “Trends in ethical and legal frameworks for the use of human biobanks,” European Respiratory Journal, vol. 30, no. 2, pp. 373–382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. Access to documents held by public bodies and the protection of personal information, An Act respecting, R.S.Q., chapter A-2. 1, Quebec, 1982, http://www.cai.gouv.qc.ca/indexen.html.